Pazhayattil George Sunny, Shirali Anushree C
Section of Nephrology, Yale University School of Medicine, New Haven, CT, USA.
Int J Nephrol Renovasc Dis. 2014 Dec 12;7:457-68. doi: 10.2147/IJNRD.S39747. eCollection 2014.
Pharmaceutical agents provide diagnostic and therapeutic utility that are central to patient care. However, all agents also carry adverse drug effect profiles. While most of these are clinically insignificant, some drugs may cause unacceptable toxicity that impacts negatively on patient morbidity and mortality. Recognizing adverse effects is important for administering appropriate drug doses, instituting preventive strategies, and withdrawing the offending agent due to toxicity. In the present article, we will review those drugs that are associated with impaired renal function. By focusing on pharmaceutical agents that are currently in clinical practice, we will provide an overview of nephrotoxic drugs that a treating physician is most likely to encounter. In doing so, we will summarize risk factors for nephrotoxicity, describe clinical manifestations, and address preventive and treatment strategies.
药物制剂具有诊断和治疗作用,这对患者护理至关重要。然而,所有药物也都有不良药物效应。虽然其中大多数在临床上无足轻重,但有些药物可能会导致不可接受的毒性,对患者的发病率和死亡率产生负面影响。认识到不良反应对于给予适当的药物剂量、制定预防策略以及因毒性而停用致病药物很重要。在本文中,我们将综述那些与肾功能受损相关的药物。通过关注目前临床实践中使用的药物制剂,我们将概述治疗医生最有可能遇到的肾毒性药物。在此过程中,我们将总结肾毒性的危险因素,描述临床表现,并探讨预防和治疗策略。